Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
115 studies found for:    Open Studies | "Neuroblastoma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Neuroblastoma Precision Trial
Condition: Neuroblastoma
Intervention: Other: Gene panel sequencing of tumor specimens
2 Not yet recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Condition: Neuroblastoma
Interventions: Drug: Ch14.18;   Biological: NK Cells;   Drug: Lenalidomide
3 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Condition: Neuroblastoma
Intervention: Device: FLT-PET
4 Recruiting A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Activated T lymphocyte
5 Recruiting Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Endostar;   Radiation: 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor
6 Recruiting Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma
Condition: Neuroblastoma Recurrent
Intervention: Drug: metronomic therapy
7 Available Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
Conditions: Recurrent Neuroblastoma;   Neuroblastoma
Interventions: Drug: Fenretinide Lym-X-Sorb Oral Powder;   Drug: Ketoconazole
8 Recruiting High Risk Neuroblastoma Study 1.7 of SIOP-Europe (SIOPEN)
Condition: Neuroblastoma
Interventions: Drug: Vincristine;   Drug: Aldesleukin;   Drug: ch14.18/CHO;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: G-CSF;   Drug: Busulfan;   Drug: Melphalan
9 Recruiting Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: dinutuximab beta
10 Recruiting Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: ifosfamide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Radiation: iobenguane I 131;   Radiation: radiation therapy
11 Recruiting Therapy for Children With Advanced Stage Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: topotecan;   Biological: hu14.18K322A;   Procedure: peripheral blood stem cell harvest;   Procedure: surgical resection;   Drug: cisplatin;   Drug: etoposide;   Drug: doxorubicin;   Drug: vincristine;   Drug: busulfan;   Drug: melphalan;   Biological: peripheral blood stem cell transplantation;   Biological: natural killer cell infusion;   Radiation: radiation therapy;   Biological: GM-CSF;   Biological: G-CSF;   Drug: mesna;   Drug: levetiracetam;   Biological: interleukin-2;   Drug: Isotretinoin
12 Recruiting Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Sorafenib;   Drug: Cyclophosphamide;   Drug: Topotecan
13 Not yet recruiting 3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: Fludarabine;   Genetic: GINAKIT Cells
14 Recruiting Neuroblastoma Maintenance Therapy Trial
Condition: Neuroblastoma
Intervention: Drug: Difluoromethylornithine (DFMO)
15 Recruiting Neuroblastoma Biology Study
Condition: Neuroblastoma
Intervention:
16 Recruiting 124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
Condition: Neuroblastoma
Interventions: Radiation: 124I-MIBG (no-carrier added);   Radiation: 124I-MIBG (carrier added)
17 Recruiting Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Melphalan;   Drug: Etoposide;   Drug: Carboplatin;   Biological: Autologous Stem Cell Infusion;   Biological: Granulocyte colony stimulating factor
18 Recruiting Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Conditions: Recurrent Neuroblastoma;   Neuroblastoma
Interventions: Drug: Fenretinide/LXS Oral Powder;   Drug: Ketoconazole;   Drug: Vincristine
19 Recruiting Immunomonitoring of Children With Neuroblastoma
Condition: Neuroblastoma
Intervention: Other: Immunological analyses
20 Recruiting Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: Anti-GD2 3F8 Monoclonal Antibody;   Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor);   Drug: oral isotretinoin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.